TREMELIMUMAB for Bladder cancer: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 44 adverse event reports in the FDA FAERS database where TREMELIMUMAB was used for Bladder cancer.
Most Reported Side Effects for TREMELIMUMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Pyrexia | 178 | 7.5% | 21 | 143 |
| Diarrhoea | 136 | 5.7% | 31 | 95 |
| Death | 116 | 4.9% | 116 | 17 |
| Colitis | 115 | 4.8% | 26 | 76 |
| Pneumonitis | 87 | 3.6% | 44 | 59 |
| Pneumonia | 85 | 3.6% | 36 | 76 |
| Sepsis | 82 | 3.4% | 35 | 71 |
| Vomiting | 78 | 3.3% | 11 | 70 |
| Febrile neutropenia | 72 | 3.0% | 30 | 60 |
| Malignant neoplasm progression | 68 | 2.9% | 22 | 9 |
| Abdominal pain | 64 | 2.7% | 22 | 60 |
| Dehydration | 61 | 2.6% | 21 | 58 |
| Biliary tract infection | 58 | 2.4% | 0 | 58 |
| Drug-induced liver injury | 57 | 2.4% | 11 | 36 |
| Dyspnoea | 57 | 2.4% | 23 | 32 |
Other Indications for TREMELIMUMAB
Pancreatic carcinoma (530)
Hepatocellular carcinoma (487)
Non-small cell lung cancer (448)
Pancreatic carcinoma metastatic (142)
Small cell lung cancer (80)
Squamous cell carcinoma of head and neck (68)
Bladder transitional cell carcinoma (51)
Non-small cell lung cancer metastatic (44)
Neoplasm malignant (42)
Product used for unknown indication (25)
Other Drugs Used for Bladder cancer
BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN (1,279)
PEMBROLIZUMAB (869)
GEMCITABINE (841)
CISPLATIN (780)
ENFORTUMAB VEDOTIN-EJFV (530)
NIVOLUMAB (512)
ATEZOLIZUMAB (487)
CARBOPLATIN (332)
BACILLUS CALMETTE-GUERIN ANTIGEN, UNSPECIFIED SUBSTRAIN (326)
GEMCITABINE\GEMCITABINE (240)